Yaz and Yasmin birth control lawsuits will be consolidated in Philadelphia according to a ruling by Judge Sandra Mazer Moss, Philadelphia Court of Common Pleas. Bayer, the manufacturer of the popular birth control pills Yaz and Yasmin, is facing lawsuits alleging that the pills contain risks and side effects that traditional birth control pills do not. These risks and side effects have been associated with drospirenone (DRSP), a hormone that increases the body’s potassium levels and raises the risk for other health concerns including blood clots and strokes. Other dangerous side effects include breast lumps, depression or mood changes, heart attack, high blood pressure, kidney and/or liver damage, migraines, vaginal bleeding and severe allergic reactions including swelling, hives and difficulties in breathing.
In 2008, Bayer received an FDA warning letter concerning its promotion of the birth control pills. As a result of the FDA warning letter, Bayer was forced to launch a marketing campaign explaining in greater detail the potential side effects of its birth control Yas and Yasmin.
- Epidurals and Autism - October 30, 2020
- 1 in 20 Patients Harmed by Medical Errors, New Report Finds - August 1, 2019
- Errors in Electronic Health Records: A Growing Source forMedical Malpractice Claims - May 23, 2018